BioSpace News Archive

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its second quarter 2019 financial results on Thursday, August 1, 2019.

The company predominantly assists individuals on behalf of criminal justice systems and judicial treatment programs.

Aligning for Health, a coalition of leading health insurers, providers, and vendors, is proud to support the introduction of the Social Determinants Accelerator Act a bipartisan piece of legislation introduced by Reps. Cheri Bustos (D-IL), Tom Cole (R-OK), Jim McGovern (D-MA), and Cathy McMorris Rogers (R-WA).

Genomic Health, Inc. (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Thursday, August 1 at 4:30 p.m. Eastern Time to discuss its second quarter 2019 financial results

Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today announced that its CE certificate covers a USB-C connector enabled version of the acclaimed Dario™ Blood Glucose Monitoring System.

The way cancer is treated is changing. Physicians will soon approach a patient’s cancer the same way they approach a patient’s high blood pressure — as a serious condition that, while incurable, can be managed with medications that have few side effects, according to Iuliana Shapira, MD, chief medical officer for Regional Cancer Care Associates LLC, or RCCA.

Following the announcement, IVERIC bio’s management team will host a live conference call and webcast at 8:00 a.m. Eastern Time to discuss the Company’s financial results and provide a general business update.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that its Board of Directors has approved the planned transition of Chairman, President and Chief Executive Officer Jeffrey Leiden, M.D., Ph.D, into the role of Executive Chairman of the Board, effective April 1, 2020.

Neurogene Inc., a company founded with a mission to bring life-changing medicines to patients and families affected by rare neurological diseases, today announced it has become the founding sponsor of a new program called “Detect Lysosomal Storage Diseases (LSDs)” from Invitae, a leading medical genetics company.

Myomo®, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, was recently a featured presenter at the United Brachial Plexus Network’s Camp UBPN, a worldwide initiative striving to inform and unite patients affected by brachial plexus injuries.